Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:CHR NYSE:DHX NYSE:FC NASDAQ:NEO On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCHRCheer$1.17-31.0%$1.56$1.00▼$3.45$13.61M1.0370,933 shs596,457 shsDHXDHI Group$2.43-2.4%$2.71$1.21▼$3.34$116.18M1.4865,546 shs27,878 shsFCFranklin Covey$18.87-0.9%$21.36$18.40▼$44.16$238.30M0.91134,804 shs79,181 shsNEONeoGenomics$5.80+0.7%$6.82$4.72▼$19.11$749.24M1.542.94 million shs1.84 million shs5G Stocks: The Path Forward is ProfitableEnter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCHRCheer0.00%-36.41%-20.95%-21.21%-56.02%DHXDHI Group0.00%-6.90%-17.35%+30.65%+37.29%FCFranklin Covey0.00%+1.24%-9.58%-10.65%-50.78%NEONeoGenomics0.00%+12.40%-22.56%-27.95%-63.41%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCHRCheer0.8152 of 5 stars0.05.00.00.00.01.70.6DHXDHI Group3.4063 of 5 stars3.33.00.00.02.42.51.9FCFranklin Covey3.8882 of 5 stars3.52.00.00.02.82.53.1NEONeoGenomics4.2744 of 5 stars4.25.00.00.03.03.31.3Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCHRCheer 0.00N/AN/AN/ADHXDHI Group 2.67Moderate Buy$4.5085.19% UpsideFCFranklin Covey 3.00Buy$31.0064.27% UpsideNEONeoGenomics 2.33Hold$12.75119.83% UpsideCurrent Analyst Ratings BreakdownLatest DHX, CHR, NEO, and FC Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails8/7/2025DHXDHI GroupLake Street CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeBuy ➝ Hold$3.008/4/2025NEONeoGenomicsPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price TargetOverweight ➝ Overweight$12.00 ➝ $11.007/30/2025NEONeoGenomicsMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price TargetEqual Weight ➝ Equal Weight$10.00 ➝ $8.007/30/2025NEONeoGenomicsBTIG ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Neutral7/29/2025NEONeoGenomicsNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$8.50 ➝ $8.007/29/2025NEONeoGenomicsWilliam BlairSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform ➝ Market Perform7/7/2025FCFranklin CoveyRoth CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$30.00 ➝ $27.007/3/2025FCFranklin CoveyBarrington ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform ➝ Outperform$35.005/15/2025NEONeoGenomicsGuggenheimSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageNeutral(Data available from 8/10/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCHRCheer$147.20M0.09$2.93 per share0.40$27.69 per share0.04DHXDHI Group$141.93M0.82$0.60 per share4.07$2.13 per share1.14FCFranklin Covey$287.23M0.83$2.71 per share6.96$6.35 per share2.97NEONeoGenomics$660.57M1.13$0.44 per share13.22$6.61 per share0.88Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCHRCheer$25.97MN/A0.00∞N/AN/AN/AN/AN/ADHXDHI Group$250K-$0.21N/A15.19N/A-6.97%9.02%4.54%N/AFCFranklin Covey$23.40M$0.7923.8913.981.523.81%19.08%6.12%N/ANEONeoGenomics-$78.73M-$0.81N/A64.44N/A-15.10%-2.72%-1.54%N/ALatest DHX, CHR, NEO, and FC EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails7/2/2025Q3 2025FCFranklin Covey-$0.08$0.18+$0.26-$0.11$67.49 million$67.12 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCHRCheerN/AN/AN/AN/AN/ADHXDHI GroupN/AN/AN/AN/AN/AFCFranklin CoveyN/AN/AN/AN/AN/ANEONeoGenomicsN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCHRCheerN/A8.297.66DHXDHI Group0.290.420.47FCFranklin Covey0.020.840.81NEONeoGenomics0.403.923.58Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCHRCheer18.54%DHXDHI Group69.26%FCFranklin Covey69.88%NEONeoGenomics98.50%Insider OwnershipCompanyInsider OwnershipCHRCheer41.70%DHXDHI Group13.40%FCFranklin Covey15.50%NEONeoGenomics2.40%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCHRCheer12711.64 million6.78 millionN/ADHXDHI Group53048.01 million41.58 millionOptionableFCFranklin Covey1,08412.64 million10.68 millionOptionableNEONeoGenomics2,200129.18 million126.08 millionOptionableDHX, CHR, NEO, and FC HeadlinesRecent News About These CompaniesINVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of NeoGenomics, Inc. - NEOAugust 9 at 11:35 AM | globenewswire.comWhy NeoGenomics (NEO) Stock Is Trading Up TodayAugust 8 at 6:47 AM | finance.yahoo.comNeoGenomics, Inc. (NASDAQ:NEO) Receives Consensus Recommendation of "Hold" from BrokeragesAugust 7 at 4:09 AM | marketbeat.comPiper Sandler Reiterates $11.00 Price Target for NeoGenomics (NASDAQ:NEO)August 7 at 2:53 AM | americanbankingnews.comNeoGenomics (NEO) Gets a Buy from Piper SandlerAugust 6, 2025 | theglobeandmail.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeoGenomics, Inc. - NEOAugust 6, 2025 | prnewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeoGenomics, Inc. - NEOAugust 6, 2025 | prnewswire.comNeoGenomics (NEO) Targets Opportunity at $5 billion Liquid Biopsy MarketAugust 5, 2025 | msn.comNeoGenomics (NASDAQ:NEO) Given New $11.00 Price Target at Piper SandlerAugust 5, 2025 | marketbeat.comNeoGenomics (NASDAQ:NEO) Sets New 12-Month Low - Here's WhyAugust 5, 2025 | marketbeat.comNeoGenomics, Inc. (NASDAQ:NEO) Shares Sold by TD Asset Management IncAugust 5, 2025 | marketbeat.comUniversal Beteiligungs und Servicegesellschaft mbH Invests $1.09 Million in NeoGenomics, Inc. (NASDAQ:NEO)August 3, 2025 | marketbeat.comNeoGenomics (NASDAQ:NEO) Shares Up 7.3% - Here's WhyAugust 2, 2025 | marketbeat.comNeoGenomics Earnings Call: Growth Amid ChallengesAugust 2, 2025 | theglobeandmail.comAnalysts Offer Insights on Healthcare Companies: NeoGenomics (NEO) and TNL Mediagene (TNMG)August 1, 2025 | theglobeandmail.comNeoGenomics (NEO) was downgraded to a Hold Rating at BTIGAugust 1, 2025 | theglobeandmail.comNeoGenomics (NASDAQ:NEO) Given a $8.00 Price Target at Morgan StanleyAugust 1, 2025 | americanbankingnews.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeoGenomics, Inc. - NEOJuly 31, 2025 | prnewswire.comNeoGenomics (NASDAQ:NEO) Sees Strong Trading Volume - Should You Buy?July 31, 2025 | marketbeat.comNeoGenomics (NASDAQ:NEO) Price Target Lowered to $8.00 at Morgan StanleyJuly 31, 2025 | marketbeat.comNeedham & Company LLC Issues Pessimistic Forecast for NeoGenomics (NASDAQ:NEO) Stock PriceJuly 31, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeDHX, CHR, NEO, and FC Company DescriptionsCheer NASDAQ:CHR$1.17 -0.53 (-30.97%) Closing price 08/8/2025 04:00 PM EasternExtended Trading$1.15 -0.02 (-1.79%) As of 08/8/2025 07:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Cheer Holding, Inc., through its subsidiaries, provides advertisement and content production services in the People's Republic of China. It operates through Cheers APP Internet Business and Traditional Media Businesses segments. The company also engages in mobile and online advertising, and media and entertainment businesses. In addition, it operates CHEERS app, an integrated e-commerce service with professionally produced content; CHEERS Video app, a media platform that engages users with content; and CHEERS e-Mall, an e-Mall app that offers products to the users through third party merchants through live streaming, online short videos, and online games. The company also provides CHEERS Telepathy, an artificial intelligence content creation platform; CHEERS Open Data, a platform that provides industry solutions; CheerCar, an interactive entertainment app; CheerReal, a digital collection NFT app; and production, such as short videos, online variety shows, online drama, live stream, and Cheers series. In addition, it is developing CheerChat App, a social app; and CHEERS Metaverse, a platform to provide immersive digital experiences. The company was formerly known as Glory Star New Media Group Holdings Limited and changed its name to Cheer Holding, Inc. in November 2023. Cheer Holding, Inc. was founded in 2016 and is headquartered in Beijing, the People's Republic of China.DHI Group NYSE:DHX$2.43 -0.06 (-2.41%) Closing price 08/8/2025 03:57 PM EasternExtended Trading$2.42 -0.01 (-0.41%) As of 08/8/2025 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.DHI Group, Inc. provides data, insights, and employment connections through specialized services for technology professionals and other select online communities in the United States. Its solutions include talent profiles; job postings; employer branding; and other services comprising virtual and live career events, sourcing services, and content and data services that provides tailored content to help professionals manage their careers and provide employers insight into recruiting strategies and trends. The company operates Dice that offers job postings of technology and non-technology companies for industries, such as positions for software engineers, big data professionals, systems administrators, database specialists, project managers, and various other technology and engineering professionals; and ClearanceJobs, an online career community, which matches security-cleared professionals with employers in a secure and private environment to fill the jobs that safeguard its nation. It serves small, mid-sized, and large direct employers; staffing companies; recruiting agencies; staffing and consulting firms; and marketing departments of companies, as well as direct hiring companies. The company offers its products and services primarily through its direct sales force and agency partner channel. The company was formerly known as Dice Holdings, Inc. and changed its name to DHI Group, Inc. in April 2015. DHI Group, Inc. was founded in 1990 and is headquartered in Centennial, Colorado.Franklin Covey NYSE:FC$18.87 -0.18 (-0.94%) Closing price 08/8/2025 03:59 PM EasternExtended Trading$18.84 -0.03 (-0.16%) As of 08/8/2025 05:46 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Franklin Covey Co. provides training and consulting services in the areas of execution, sales performance, productivity, customer loyalty, and educational improvement for organizations and individuals worldwide. The company operates through Direct Offices, International Licensees, and Education Practice segments. It also provides a suite of individual-effectiveness and leadership-development training and products. In addition, the company operates Strive platform, a learning deployment platform; Impact platform that helps automate implementation of learning initiatives; All Access Pass, a subscription platform that enables improved deployment of content, services, technology, and metrics to deliver behavioral impact at scale; and Leader in Me, which provides access to digital versions of student leadership guides, leadership lessons, illustrated leadership stories, and other resources. Franklin Covey Co. was incorporated in 1983 and is headquartered in Salt Lake City, Utah.NeoGenomics NASDAQ:NEO$5.80 +0.04 (+0.69%) Closing price 08/8/2025 04:00 PM EasternExtended Trading$5.74 -0.06 (-1.03%) As of 08/8/2025 05:06 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through Clinical Services and Advanced Diagnostics segments. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 08/04 - 08/08 Rocket Lab Reports Q2 Results: Is the Bull Thesis Still Intact? Airbnb Beats Earnings, But the Growth Story Is Losing Altitude Dutch Bros Just Flipped the Script With a Massive Earnings Beat Amazon Takes an Equity Stake in IonQ—Any Upside Potential? D-Wave Delivers Growth Shock—Investors Eye Quantum Future Is Eli Lilly’s 14% Post-Earnings Slide a Buy-the-Dip Opportunity? Constellation Energy’s Earnings Beat Signals a New Era Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
